Reports - Prescription Drugs Market
HealthcarePrescription Drugs Market
Prescription Drugs Market Size and Share Analysis for 2035 by Type (Branded, Generic) by Therapy Area (Oncology, Immunology, Ophthalmology, Respiratory, Dermatology, Gastroenterology, Urology, Gynaecology, Endocrinology, Other Therapy Areas) by Route of Administration (Oral, Topical, Parenteral, Other Routes of Administration) by End-Users (Hospitals, Specialty Clinics, Homecare, Other End-Users) by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Prescription Drugs Market - Segment Analysis
1. Overview
2. Global Prescription Drugs Market, 2021 - 2035 (USD Million)
3. Global Prescription Drugs Market - by Type
3.1. By Branded
3.2. By Generic
4. Global Prescription Drugs Market - by Therapy Area
4.1. By Oncology
4.2. By Immunology
4.3. By Ophthalmology
4.4. By Respiratory
4.5. By Dermatology
4.6. By Gastroenterology
4.7. By Urology
4.8. By Gynaecology
4.9. By Endocrinology
4.10. By Other Therapy Areas
5. Global Prescription Drugs Market - by Route of Administration
5.1. By Oral
5.2. By Topical
5.3. By Parenteral
5.4. By Other Routes of Administration
6. Global Prescription Drugs Market - by End-Users
6.1. By Hospitals
6.2. By Specialty Clinics
6.3. By Homecare
6.4. By Other End-Users
7. Global Prescription Drugs Market - by Distribution Channel
7.1. By Hospital Pharmacy
7.2. By Retail Pharmacy
7.3. By Online Pharmacy
7.4. By Other Distribution Channels
8. Global Prescription Drugs Market - by region
8.1. North America
8.2. Europe
8.3. Asia Pacific
8.4. Latin America
8.5. Middle East & Africa
9. Market comparative analysis
Chapter 4 North America Prescription Drugs Market - Segment Analysis
1. Overview
2. North America Prescription Drugs Market, 2021 - 2035 (USD Million)
3. North America Prescription Drugs Market - by Type
3.1. By Branded
3.2. By Generic
4. North America Prescription Drugs Market - by Therapy Area
4.1. By Oncology
4.2. By Immunology
4.3. By Ophthalmology
4.4. By Respiratory
4.5. By Dermatology
4.6. By Gastroenterology
4.7. By Urology
4.8. By Gynaecology
4.9. By Endocrinology
4.10. By Other Therapy Areas
5. North America Prescription Drugs Market - by Route of Administration
5.1. By Oral
5.2. By Topical
5.3. By Parenteral
5.4. By Other Routes of Administration
6. North America Prescription Drugs Market - by End-Users
6.1. By Hospitals
6.2. By Specialty Clinics
6.3. By Homecare
6.4. By Other End-Users
7. North America Prescription Drugs Market - by Distribution Channel
7.1. By Hospital Pharmacy
7.2. By Retail Pharmacy
7.3. By Online Pharmacy
7.4. By Other Distribution Channels
Chapter 5 Europe Prescription Drugs Market - Segment Analysis
1. Overview
2. Europe Prescription Drugs Market, 2021 - 2035 (USD Million)
3. Europe Prescription Drugs Market - by Type
3.1. By Branded
3.2. By Generic
4. Europe Prescription Drugs Market - by Therapy Area
4.1. By Oncology
4.2. By Immunology
4.3. By Ophthalmology
4.4. By Respiratory
4.5. By Dermatology
4.6. By Gastroenterology
4.7. By Urology
4.8. By Gynaecology
4.9. By Endocrinology
4.10. By Other Therapy Areas
5. Europe Prescription Drugs Market - by Route of Administration
5.1. By Oral
5.2. By Topical
5.3. By Parenteral
5.4. By Other Routes of Administration
6. Europe Prescription Drugs Market - by End-Users
6.1. By Hospitals
6.2. By Specialty Clinics
6.3. By Homecare
6.4. By Other End-Users
7. Europe Prescription Drugs Market - by Distribution Channel
7.1. By Hospital Pharmacy
7.2. By Retail Pharmacy
7.3. By Online Pharmacy
7.4. By Other Distribution Channels
Chapter 6 Asia Pacific Prescription Drugs Market - Segment Analysis
1. Overview
2. Asia Pacific Prescription Drugs Market, 2021 - 2035 (USD Million)
3. Asia Pacific Prescription Drugs Market - by Type
3.1. By Branded
3.2. By Generic
4. Asia Pacific Prescription Drugs Market - by Therapy Area
4.1. By Oncology
4.2. By Immunology
4.3. By Ophthalmology
4.4. By Respiratory
4.5. By Dermatology
4.6. By Gastroenterology
4.7. By Urology
4.8. By Gynaecology
4.9. By Endocrinology
4.10. By Other Therapy Areas
5. Asia Pacific Prescription Drugs Market - by Route of Administration
5.1. By Oral
5.2. By Topical
5.3. By Parenteral
5.4. By Other Routes of Administration
6. Asia Pacific Prescription Drugs Market - by End-Users
6.1. By Hospitals
6.2. By Specialty Clinics
6.3. By Homecare
6.4. By Other End-Users
7. Asia Pacific Prescription Drugs Market - by Distribution Channel
7.1. By Hospital Pharmacy
7.2. By Retail Pharmacy
7.3. By Online Pharmacy
7.4. By Other Distribution Channels
Chapter 7 Latin America Prescription Drugs Market - Segment Analysis
1. Overview
2. Latin America Prescription Drugs Market, 2021 - 2035 (USD Million)
3. Latin America Prescription Drugs Market - by Type
3.1. By Branded
3.2. By Generic
4. Latin America Prescription Drugs Market - by Therapy Area
4.1. By Oncology
4.2. By Immunology
4.3. By Ophthalmology
4.4. By Respiratory
4.5. By Dermatology
4.6. By Gastroenterology
4.7. By Urology
4.8. By Gynaecology
4.9. By Endocrinology
4.10. By Other Therapy Areas
5. Latin America Prescription Drugs Market - by Route of Administration
5.1. By Oral
5.2. By Topical
5.3. By Parenteral
5.4. By Other Routes of Administration
6. Latin America Prescription Drugs Market - by End-Users
6.1. By Hospitals
6.2. By Specialty Clinics
6.3. By Homecare
6.4. By Other End-Users
7. Latin America Prescription Drugs Market - by Distribution Channel
7.1. By Hospital Pharmacy
7.2. By Retail Pharmacy
7.3. By Online Pharmacy
7.4. By Other Distribution Channels
Chapter 8 Middle East & Africa Prescription Drugs Market - Segment Analysis
1. Overview
2. Middle East & Africa Prescription Drugs Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Prescription Drugs Market - by Type
3.1. By Branded
3.2. By Generic
4. Middle East & Africa Prescription Drugs Market - by Therapy Area
4.1. By Oncology
4.2. By Immunology
4.3. By Ophthalmology
4.4. By Respiratory
4.5. By Dermatology
4.6. By Gastroenterology
4.7. By Urology
4.8. By Gynaecology
4.9. By Endocrinology
4.10. By Other Therapy Areas
5. Middle East & Africa Prescription Drugs Market - by Route of Administration
5.1. By Oral
5.2. By Topical
5.3. By Parenteral
5.4. By Other Routes of Administration
6. Middle East & Africa Prescription Drugs Market - by End-Users
6.1. By Hospitals
6.2. By Specialty Clinics
6.3. By Homecare
6.4. By Other End-Users
7. Middle East & Africa Prescription Drugs Market - by Distribution Channel
7.1. By Hospital Pharmacy
7.2. By Retail Pharmacy
7.3. By Online Pharmacy
7.4. By Other Distribution Channels
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. F. Hoffmann-La Roche Ltd. (Switzerland)
2. Mylan N.V. (U.S.)
3. Teva Pharmaceutical Industries Ltd. (Ireland)
4. Sanofi (France)
5. Pfizer Inc. (U.S.)
6. GlaxoSmithKline PLC (UK)
7. Novartis AG (Switzerland)
8. Merck & Co. Inc. (U.S.)
9. Allergan (Ireland)
10. AstraZeneca (UK)
11. Johnson & Johnson Private Limited (U.S.)
12. Hikma Pharmaceuticals PLC (UK)
13. Bristol-Myers Squibb Company (U.S.)
14. Bayer AG (Germany)
15. Boehringer Ingelheim International GmbH (Germany)
16. Dr. Reddys Laboratories Ltd. (India)
17. Gilead Sciences Inc. (U.S.)
18. Amgen Inc. (U.S.)
19. Eli Lilly & Company (U.S.)
20. AbbVie Inc. (U.S.)
21. Lupin (India)
22. Allergan (Ireland)
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By